Aquestive Therapeutics, Inc. ($AQST)
Filing Information
| Accession Number | 0001214659-26-003146 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
965,677
Total Value
$2,997,635.12
P&L
+39.2% (+$880,630.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and CEO | Common Stock | โ | Mar 9, 2026 | Grant/Award | 262,000 | $0.00 | $0.00 | 1,185,430 | Direct | โ | View Details | |
President and CEO | Common Stock | โ | Mar 10, 2026 | Sale | 180,677 | $4.17 | $753,965.12 | 1,004,753 | Direct | โ | View Details | |
President and CEO | Non-Qualified Stock Option (right to buy) | Derivative | Mar 9, 2026 | Grant/Award | 523,000 | $4.29 | $2,243,670.00 | 523,000 | Direct | โ | View Details |